FDA’s Project Optimus Guidance: Highlights and Tips for Success for Oncology Drug Developers
January 2023 guidance from FDA on dosages in oncology provides further context on expectations with Project Optimus.
Leveraging Modeling & Simulation in Oncology
How the use of M&S in cancer trials from the outset can help address those critical “what if?” scenarios and accelerate oncology drug development.